A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a ... the immune system, but do not cure the virus.

This process destroys the immune system’s ability to fight infections and generally prevents the body from working well. There is currently no known cure ... HIV DNA into human DNA.

On Wednesday, Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025).

its functional cure candidate for human immunodeficiency virus (HIV). The data, presented in an oral session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025, in San ...

“Our contributions to CROI spotlight our dedication to scientific discovery, reflect our commitment to addressing the diverse treatment needs and preferences of communities affected by HIV and ...

However, this whole system is in jeopardy ... to develop lifesaving services for people living with HIV to access HIV treatment, care, and support. The Care Act has also been enthusiastically ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Biktarvy maintained HIV-1 suppression in 95.4% and HBV suppression in 86.6% of participants after 96 weeks of treatment switch. Lenacapavir with teropavimab and zinlirvimab showed 96% virologic ...

--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and ...